NASDAQ:AIDX | Cash Flow Statement | 20/20 Biolabs, Inc.

Complete source-backed cash-flow history.

Available history
2024-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.51M
2026-03-31-$2.17M$12,306.00-$1.29M-$5,354.00$4.49M
2025-06-30-$840,933.00
2025-03-31-$764,577.00$17,825.00-$488,293.00$262,338.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$3.74M$63,257.00-$1.92M$1.16M
2024-12-31-$5.55M$116,035.00-$2.6M$293,333.00